Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Proposal For Cybersecurity Info In Pre-market Submissions Generates Debate

This article was originally published in The Gray Sheet

Executive Summary

Medical device firms and internet security groups disagree over whether an FDA guidance should recommend that companies document their cybersecurity measures in pre-market submissions.


Related Content

Responding To Cybersecurity Threats: FDA Addresses Postmarket Questions In Draft Guidance
FDA Sticks With Premarket Plans In Cybersecurity Guidance
Hack Attack On Hospital System Highlights Need For Device Cybersecurity
HHS, HITRUST Team Up For Simulated Cyberattacks On Health Industry
FDA Cybersecurity Efforts Emphasize Collaboration With Homeland Security Officials, Hospitals
FDA Aims To Stay Ahead Of Wireless Technology Upgrades With Final Guidance
FDA Proposes New Cybersecurity Submission Standards For Devices


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts